Ligand Pharmaceuticals Inc · Cash & Short-Term Investments

Latest reported$733.52Mperiod endingDec 31, 2025

LGND FY Cash & Short-Term Investments ($7.60M → $733.52M)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

LGND cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	733,521,000
Dec 31, 2024	256,165,000
Dec 31, 2023	170,309,000
Dec 31, 2022	211,870,000
Dec 31, 2021	341,108,000
Dec 31, 2020	411,186,000
Dec 31, 2019	1,069,867,000
Dec 31, 2018	764,572,000
Dec 31, 2017	201,661,000
Dec 31, 2016	141,048,000
Dec 31, 2015	200,219,000
Dec 31, 2014	167,336,000
Dec 31, 2013	15,979,000
Dec 31, 2012	12,381,000
Dec 31, 2011	17,041,000
Dec 31, 2010	22,697,000
Dec 31, 2009	53,232,000
Dec 31, 2008	80,671,000
Dec 31, 2007	94,408,000
Dec 31, 2006	171,848,000
Dec 31, 2005	86,930,000
Dec 31, 2004	112,492,000
Dec 31, 2003	99,034,000
Dec 31, 2002	64,248,000
Dec 31, 2001	37,688,000
Dec 31, 2000	23,663,000
Dec 31, 1999	47,200,000
Dec 31, 1998	32,800,000
Dec 31, 1997	62,300,000
Dec 31, 1996	34,800,000
Dec 31, 1995	16,000,000
Dec 31, 1994	7,600,000